Glycostem CEO Troels Jordansen and CMO Kai Pinkernell to present at the Advanced Therapies Europe, on 1^st Sep 2022 in the below sessions:

09:00 SPOTLIGHT ROUNDTABLES
ROUNDTABLE 6: PATIENT ENGAGEMENT DURING CLINICAL DEVELOPMENT: KEEPING THE ‘CUSTOMER’ IN MIND 
Moderator: Kai Pinkernell, Chief Medical Officer, Glycostem

13:55 – CASE STUDY: OPTIMISING FACILITY & LOCATION FOR CANCER CARE
Speaker: Troels Jordansen, CEO, Glycostem Therapeutics
 

Glycostem CDO Volker Huppert will present at the webinar Natural Killer Cells: Progress and Promise co-organized by Xtalks and Akron Biotech on Thursday, 18 August 2022 17:00 CET. The goal of this webinar is to provide a 360-degree view of the progress being made in NK cells, including technology, manufacturing and the promise and challenges as they move into the clinic.

Glycostem will participate EHA2022 Congress in Vienna from 9^th to 12^th June 2022.

Glycostem is going to participate Advanced Therapies Congress in London on 24^th May, 2022. Meet us in the following session:

Time: 14:10 GMT +1 
Presentation: Manufacturing genetically modified NK cells

Glycostem Chief Development Officer Volker Huppert is going to present at the 2022 BioProcess International Europe on 17^th May, 2022.

Presentation title: Platform Approaches for Process Understanding Across Different Biopharmaceutical Sectors: Varying Starting Raw Material in ATMP Processes
Session: Cell & Gene Therapy
Time and date: Tuesday, 17^th May 2022 14:15 - 14:45 CET

Glycostem is attending Bio€quity Europe 2022, from the 16^th - 18^th May 2022.

To book one-to-one partnering meeting with our CEO Troels Jordansen, search "Glycostem" in the partnering platform.